SEC Form 4 · accession 0001144204-17-023240
Moleculin Biotech, Inc. · MBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E. George
Director
Period of report
Apr 28, 2017
Accepted (ET)
Apr 28, 2017 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001659617
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 28, 2017 | P | 1,000 | $0.9384 | A | 1,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24 - Limited Power of Attorney